BCL2 and breast carcinoma: This was reported in breast cancer by Li et al., (2017) who found that restoring expression of miR-148a suppressed the expression of Bcl-2 at the level of both mRNA and protein, and also upregulation of miR-148a caused a subsequent reduction of proliferation and an increase in apoptosis, confirming their involvement in the oncogenesis of breast cancer.